Subscribe to RSS Feed for recent updates
Subscribe to RSS Feed for recent updates







This member is a YANA Mentor This is his Country or State Flag Member's Photo

Carl Vilbrandt and Jody live in Oregon, USA. He was 72 when he was diagnosed in September, 2016. His initial PSA was 8.90 ng/ml, his Gleason Score was 7b, and he was staged T2a. His choice of treatment was Undecided. Here is his story.

Ok, it has been a month and a half. We (Jody and I) have found the yananow site a very valuable resource. We think that a brief past history of my health is of import to this blog. We will compile this later on. However by way of introduction please find the following google doc links. Images and other links to be added.

A brief personal history is of importance to the prevention of Cancer. The medical industry focuses on the diction and cure of cancer as a profit center. OHSU takes a passing interest even in my past or current diet or activities. In other words, Cancer treatment is not from our point of view personal.

We (Jody and I) are rather disturbed about this. Interview - "The Secret History of the War on Cancer" gives a view of why prevention is of such importance. If you want to prevent the return of Cancer gets the audio-book. The scope of the book is incredible it's a long read. We suggest the audio-book. It is available for free through you local or not so local library.
Interview with the author - https://www.youtube.com/watch?v=uKsf6WtvxEE

Before the Cancer diagnosis, we listened to "the emperor of all maladies" audio-book. The history is as gruesome as it is interesting. Winner of the Pulitzer Prize, and now a documentary from Ken Burns on PBS, A must see if you have Cancer of any type.

We feel it's important for people with Cancer to understand the history. We have found the current state of treatment of Cancer is only a little better now as in the past. The general prostate Cancer treatment is to kill it by cutting, sunburn, or cooking it.

The links to the medical documentation:

PSA History graph:


You can see the jump in the PSA. I was lucky to get an MRI done before a biopsy was done. The MRI-guided the biopsy. If I had not had the MRI images cancer would not have been found at all. See a description of biopsy below the MRI report.

The detail report from the Magnetic Resonance Imaging MRI with a rather large coil / antenna in my rectum. Using meditation I was able to not move a twitch resulting in very good images.

It is of great importance to learn how to read and understand this report. Below is a copy of my MRI. One of the things to important to notice is the Cancer is in only one location. It seems to start in my right nerve bundle and is moving out from that location. This means it most likely is caused by industrial exposure cadmium over 30 years ago.

A large tumor was found it turned out not to be Cancer. However I was lucky again if the tumor was not found the biopsy would not have been done. Wow...

  1. EXAM: MRI Prostate with and without intravenous contrast.
  2. HISTORY: Elevated PSA=9, evaluate for prostate cancer
  3. COMPARISON: None.
  4. TECHNIQUE: Endorectal multiparametric and multiplanar MRI of the prostate
  5. performed, including axial T1 images of the pelvis and high resolution axial
  6. T2, diffusion, and perfusion pre-and post dynamic intravenous gadolinium images
  7. of the prostate.
  9. The prostate measures 5.7 CM transverse by 4.9 CM anteroposterior by 5.9 CM
  10. craniocaudal, giving a gland volume of 85 mL . No post-biopsy hemorrhage noted
  11. on T1 weighted images.
  12. A dominant tumor focus is identified in the right anterior central gland,
  13. measuring 1.4 CM transverse by 2 CM anteroposterior by 2.6 CM craniocaudal,
  14. giving a tumor volume of 3.8 mL . The tumor demonstrates:
  15. Low T2 signal: Yes, mildly heterogenous.
  16. Restricted diffusion: Yes, mildly heterogenous hypointense signal .
  17. Early enhancement: Yes.
  18. Delayed washout: No.
  19. Overall Pi-RADS classification:
  20. 4, based on the T2 and ADC heterogeneity.
  21. With respect to tumor stage:
  22. Likelihood of right-sided extracapsular extension: Absent (0-20%).
  23. Likelihood of left-sided extracapsular extension: Absent (0-20%).
  24. Likelihood of right-sided seminal vesicle invasion: Absent (0-20%).
  25. Likelihood of left-sided seminal vesicle invasion: Absent (0-20%).
  26. A peripheral left central gland focus at the base of the prostate with
  27. heterogenous diffusion restriction and washout is encapsulated and compatible
  28. with a BPH nodule. Urinary bladder trabeculations are noted secondary to
  29. chronic bladder obstruction. No lymphadenopathy, suspicious bone lesions, or
  30. other abnormality identified.
  32. 1. Dominant right paramedian anterior central gland PI-RADS 4 focus, suspicious
  33. for malignancy. This is amenable to direct of fusion guided biopsy.
  34. 2. Moderate prostatomegaly, with changes of benign prostatic hyperplasia.
  35. Recent literature on likelihood of prostate cancer by scenario:
  36. Repeat biopsy positive in 5 of 112 patients (4.5%) with negative MRI and prior
  37. negative TRUS biopsy (J Urol 2014; 192: 60-66).
  38. Repeat biopsy positive in 47 of 58 patients (81.0%) with positive MRI and prior
  39. negative TRUS biopsy (J Urol 2014; 192: 60-66).
  40. Biopsy positive in 33 of 151 (21.8%) low risk biopsy naive patients (PSA < 10
  41. and negative digital rectal exam) with negative MRI (J Urol 2013; 190: 502-8).
  42. Biopsy positive in 23 of 43 (53.4%) high risk biopsy naive patients (PSA > 10
  43. or positive digital rectal exam) with negative MRI (J Urol 2013; 190: 502-8).
  44. Biopsy positive in 53 of 94 (56.4%) low risk biopsy naive patients (PSA < 10
  45. and negative digital rectal exam) with positive MRI (J Urol 2013; 190: 502-8).
  46. Biopsy positive in 48 of 63 (76.1%) high risk biopsy naive patients (PSA > 10
  47. or positive digital rectal exam) with positive MRI (J Urol 2013; 190: 502-8).

Attending Radiologists: JOYCE MHLANGA, MBBCH

I personally reviewed the images and, if necessary, edited the report. I agree with the report as now presented.


An MRI should be a standard procedure done before a biopsy. I would have had the typical 12 core biopsy that leaves the lower section (hard to get at) unsampled. So I had a 19 core biopsy (7 more cores lower that a typical biopsy was taken) or cancer would not have been detected.

One of the things to important to notice in the biopsy below is the Cancer is in only one location. It seems to start in my right nerve bundle and is moving out from that location. This means it most likely is caused by industrial exposure cadmium over 30 years ago.

1. Have an MRI before a biopsy ... force them to... it should be standard procedure.
2. The standard 12 core biopsy is missing early cancer. Have a 19 added lower than the standard procedure. This has really saved my life ... I am very lucky. Important contamination / small particles /toxins enter the pancreas by traveling down the nerve bundles.
3. Learn how to read your biopsy and keep track. We found doctors report that stated a 3-4 condition when the biopsy stated a 4-3. Its a big difference. We have had to correct doctors mistakes several times. You must take active care of your self.

A strong immune system kills cancer. If the immune system is damage Cancer can exist. however Cancer can only grow if the testosterone promotes growth. It allows the cancer to grow blood vessels (this is called angiogensis). Turning off the blood vessel growth can be done by diet. Angiogenesis inhibitors / anti-angiogenesis food prohibit cancer from growing blood vessels. I have had for several years an anti-angiogenesis diet. Thus its a good bet the Cancer I have has evolved to promote its own growth in response to my diet. Citations / links for the above claims in next update.

Carl's e-mail address is: carl@applied3d.org